Esteve J, López-Guillermo A, Martínez-Francés A, Bosch F, Terol M J, Campo E, Montserrat E, Rozman C
Postgraduate School of Hematology Farreras Valenti, Department of Medicine, Barcelona, Spain.
Eur J Haematol. 1995 Oct;55(4):217-22. doi: 10.1111/j.1600-0609.1995.tb00260.x.
Clinical features and prognostic factors were analyzed in a series of 117 patients with localized non-Hodgkin's lymphoma (stage I-II). Median age of the patients was 53 years and 52% were men; 22% had a lymphoma of low-grade histology and one-third presented with extranodal involvement. Eighty percent of the patients achieved a complete response (CR); stage of disease and histology were revealed as the most important factors for response. When analysis was restricted to intermediate/high-grade cases, stage showed a predictive value for response. With a median follow-up of 4.5 years, median overall survival was 12.0 years, with 73% and 62.5% of patients being alive at 5 and 10 years, respectively. Main initial parameters significantly related to a shorter survival were intermediate/high-grade histology, stage II, poor performance status, bulky disease, high serum LDH levels, increased ESR, and advanced International Index. In the multivariate analysis, stage, histology and performance status (PS) were statistically significant. Among intermediate/high-grade lymphoma patients, stage and PS provided prognostic value for survival. Twenty-six patients relapsed after CR; median survival after relapse was 2.7 years. Stage (I vs II) was the only predictive variable for relapse in both the whole series and the intermediate/high-grade subset.
对117例局限性非霍奇金淋巴瘤(I-II期)患者的临床特征和预后因素进行了分析。患者的中位年龄为53岁,52%为男性;22%患有低级别组织学淋巴瘤,三分之一患者有结外受累表现。80%的患者达到完全缓解(CR);疾病分期和组织学被证明是影响缓解的最重要因素。当分析仅限于中/高级别病例时,分期显示出对缓解的预测价值。中位随访4.5年,中位总生存期为12.0年,5年和10年时分别有73%和62.5%的患者存活。与较短生存期显著相关的主要初始参数为中/高级别组织学、II期、较差的体能状态、大包块病变、高血清乳酸脱氢酶水平、血沉加快以及较高的国际预后指数。在多变量分析中,分期、组织学和体能状态(PS)具有统计学意义。在中/高级别淋巴瘤患者中,分期和PS对生存具有预后价值。26例患者在CR后复发;复发后的中位生存期为2.7年。分期(I期与II期)是整个系列以及中/高级别亚组中复发的唯一预测变量。